Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes-Reference-Cited by-同舟云学术

Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes

Published:2020-09-16 Issue:6 Volume:7 Page:4089-4099
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Kanagala Prathap¹²³^ORCID,Arnold Jayanth R.¹,Khan Jamal N.¹,Singh Anvesha¹,Gulsin Gaurav S.¹,Eltayeb Mohamed¹,Gupta Pankaj¹,Squire Iain B.¹,McCann Gerry P.¹,Ng Leong L.¹

Affiliation:

1. Department of Cardiovascular Sciences University of Leicester, National Institute for Health Research (NIHR) Leicester Biomedical Research Centre Leicester UK

2. Aintree University Hospital Liverpool UK

3. Liverpool Centre for Cardiovascular Science Liverpool UK

Funder

National Institute for Health Research

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13020

Reference29 articles.

1. Heart failure with preserved ejection fraction: a clinical dilemma